Cybin (HELP) Operating Leases (2023 - 2024)

Cybin's (HELP) quarterly Operating Leases came in at $97496.1 in Q3 2024, down 37.1% on a QoQ basis from $155001.8 in Q2 2024.

Cybin (HELP) Operating Leases (2023 - 2024) Analysis & Trends

Cybin (HELP) has 2 years of Operating Leases data on file, last reported at $97496.1 in Q3 2024.

Quarterly Operating Leases changed N/A year-over-year to $97496.1 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $97496.1 (changed N/A YoY) and the FY2024 annual result came in at $215954.9, changed N/A from the prior year.
Operating Leases retreated to $97496.1 in Q3 2024, from $155001.8 in the prior quarter.
In the past five years, Operating Leases ranged from a high of $237989.5 in Q4 2023 to a low of $97496.1 in Q3 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	Cybin	417.29 Mn	417.29 Mn	-

Download Data